當(dāng)前位置：首頁 SCI期刊 SCIE期刊醫(yī)學(xué) 中科院4區(qū) JCRQ2 期刊介紹(非官網(wǎng))

Cell TransplantationSCIE

國際簡稱：CELL TRANSPLANT 參考譯名：細(xì)胞移植

中科院分區(qū)
4區(qū)
CiteScore分區(qū)
Q2
JCR分區(qū)
Q2

基本信息：: ISSN：0963-6897; E-ISSN：1555-3892; 是否OA：開放; 是否預(yù)警：否; TOP期刊：否

出版信息：: 出版地區(qū)：UNITED STATES; 出版商：SAGE Publications Inc.; 出版語言：English; 出版周期：Bimonthly; 出版年份：1992; 研究方向：生物-細(xì)胞與組織工程

評價信息：: 影響因子：3.2; H-index：90; CiteScore指數(shù)：6; SJR指數(shù)：0.701; SNIP指數(shù)：0.625

發(fā)文數(shù)據(jù)：: Gold OA文章占比：95.50%; 研究類文章占比：79.81%; 年發(fā)文量：104; 自引率：0.0303...; 開源占比：0.9569; 出版撤稿占比：0; 出版國人文章占比：0.29; OA被引用占比：1

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介Cell Transplantation期刊介紹

Cell Transplantation, The Regenerative Medicine Journal is an open access, peer reviewed journal that is published 12 times annually. Cell Transplantation is a multi-disciplinary forum for publication of articles on cell transplantation and its applications to human diseases. Articles focus on a myriad of topics including the physiological, medical, pre-clinical, tissue engineering, stem cell, and device-oriented aspects of the nervous, endocrine, cardiovascular, and endothelial systems, as well as genetically engineered cells. Cell Transplantation also reports on relevant technological advances, clinical studies, and regulatory considerations related to the implantation of cells into the body in order to provide complete coverage of the field.

期刊簡介Cell Transplantation期刊介紹

《Cell Transplantation》自1992出版以來，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個領(lǐng)域的原創(chuàng)研究提供一個展示平臺，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見解，或?qū)彶槎嗄陙砟硞€重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時報道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點：

預(yù)計審稿時間：約1月
醫(yī)學(xué)
CELL & TISSUE ENGINEERING
SCIE
中科院4區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Cell Transplantation Cite Score數(shù)據(jù)

CiteScore：6
SJR：0.701
SNIP：0.625

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Transplantation	Q2	15 / 54	73%
大類：Medicine 小類：Biomedical Engineering	Q2	114 / 303	62%
大類：Medicine 小類：Cell Biology	Q3	166 / 285	41%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻(xiàn)計量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎(chǔ)，針對的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標(biāo)來評價。

歷年Cite Score趨勢圖

中科院SCI分區(qū)Cell Transplantation 中科院分區(qū)

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	4區(qū)	CELL & TISSUE ENGINEERING 細(xì)胞與組織工程 MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實驗 TRANSPLANTATION 移植	4區(qū) 4區(qū) 4區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運用科學(xué)計量學(xué)方法對國際、國內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級劃分的期刊評價標(biāo)準(zhǔn)。它為我國科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評價國際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個層次，類似于“優(yōu)、良、及格”等。最開始，這個分區(qū)只是為了方便圖書管理及圖書情報領(lǐng)域的研究和期刊評估。之后中科院分區(qū)逐步發(fā)展成為了一種評價學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢圖

JCR分區(qū)Cell Transplantation JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CELL & TISSUE ENGINEERING	SCIE	Q3	19 / 31	40.3%
學(xué)科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q2	81 / 189	57.4%
學(xué)科：TRANSPLANTATION	SCIE	Q2	10 / 31	69.4%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CELL & TISSUE ENGINEERING	SCIE	Q3	16 / 31	50%
學(xué)科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q2	74 / 189	61.11%
學(xué)科：TRANSPLANTATION	SCIE	Q2	13 / 31	59.68%

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評估。不同學(xué)科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質(zhì)量可能是存在一定問題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發(fā)文數(shù)據(jù)

2023-2024 年國家/地區(qū)發(fā)文量統(tǒng)計

國家/地區(qū)數(shù)量
USA256
CHINA MAINLAND237
Taiwan50
Japan40
Italy23
South Korea19
Sweden17
England16
GERMANY (FED REP GER)16
Australia14

本刊中國學(xué)者近年發(fā)表論文

1、circSOBP Inhibits Bladder Cancer Proliferation and Metastasis by Regulating the miR-200a-3p/PTEN Axis and Participating in the Immune Response
Author: Zhang, Yinglang; Li, Zhi; Zhang, Yu; Shen, Chong; Zhang, Zhe; Ren, Xiaolei; Guo, Changgang; Yang, Shaobo; Wang, Zejin; Hu, Hailong

Journal: CELL TRANSPLANTATION. 2023; Vol. 32, Issue , pp. -. DOI: 10.1177/09636897231165874
2、Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6
Author: Wang, Jiantao; Yang, Chuan; Cao, Huan; Yang, Jianwang; Meng, Wenxia; Yu, Miaomiao; Yu, Lei; Wang, Baoshan

Journal: CELL TRANSPLANTATION. 2023; Vol. 32, Issue , pp. -. DOI: 10.1177/09636897231154574
3、Derivation of Sendai-Virus-Reprogrammed Human iPSCs-Neuronal Precursors: In Vitro and In Vivo Post-grafting Safety Characterization
Author: Shigyo, Michiko; Kobayashi, Yoshiomi; Platoshyn, Oleksandr; Marsala, Silvia; Kato Jr, Tomohisa; Takamura, Naoki; Yoshida, Kenji; Kishino, Akiyoshi; Bravo-Hernandez, Mariana; Juhas, Stefan; Juhasova, Jana; Studenovska, Hana; Proks, Vladimir; Ciacci, Joseph D.; Marsala, Martin

Journal: CELL TRANSPLANTATION. 2023; Vol. 32, Issue , pp. -. DOI: 10.1177/09636897231163232
4、Human Menstrual Blood-Derived Endometrial Stem Cells Promote Functional Recovery by Improving the Inflammatory Microenvironment in a Mouse Spinal Cord Injury Model
Author: Shi, Yaping; Liu, Yunfei; Zhang, Bichao; Li, Xiaoying; Lin, Juntang; Yang, Ciqing

Journal: CELL TRANSPLANTATION. 2023; Vol. 32, Issue , pp. -. DOI: 10.1177/09636897231154579
5、Donor Hematopoietic Stem Cell/Lymphocyte Maintenance Treatment After CAR T-Cell Therapy in Patients With B-Cell Acute Lymphoblastic Leukemia Relapse Following Stem Cell Transplant
Author: Li, Qing; Lyu, Cuicui; Liu, Meijing; Wang, Jia; Mou, Nan; Jiang, Erlie; Zhang, Rongli; Deng, Qi

Journal: CELL TRANSPLANTATION. 2023; Vol. 32, Issue , pp. -. DOI: 10.1177/09636897231158155
6、Elevated Angiotensin-II Levels Contribute to the Pathogenesis of Open-Angle Glaucoma Via Inducing the Expression of Fibrosis-Related Genes in Trabecular Meshwork Cells Through a ROS/NOX4/SMAD3 Axis
Author: Li, Haijun; Cui, Huiling; Ren, Jing; Wang, Di; Zhao, Rumeng; Zhu, Shichao; Liu, Siqing; Liu, Xiaohui; Tian, Shuai; Zhang, Yuanyuan; Zhao, Panpan; Li, Peng; Thorne, Rick F.; Duan, Shichao

Journal: CELL TRANSPLANTATION. 2023; Vol. 32, Issue , pp. -. DOI: 10.1177/09636897231162526
7、Expandable Sendai-Virus-Reprogrammed Human iPSC-Neuronal Precursors: In Vivo Post-Grafting Safety Characterization in Rats and Adult Pig
Author: Kobayashi, Yoshiomi; Shigyo, Michiko; Platoshyn, Oleksandr; Marsala, Silvia; Kato Jr, Tomohisa; Takamura, Naoki; Yoshida, Kenji; Kishino, Akiyoshi; Bravo-Hernandez, Mariana; Juhas, Stefan; Juhasova, Jana; Studenovska, Hana; Proks, Vladimir; Driscoll, Shawn P.; Glenn, Thomas D.; Pfaff, Samuel L.; Ciacci, Joseph D.; Marsala, Martin

Journal: CELL TRANSPLANTATION. 2023; Vol. 32, Issue , pp. -. DOI: 10.1177/09636897221107009
8、Clinical Outcomes by Consolidation of Bone Marrow Stem Cell Therapy and Coronary Artery Bypass Graft in Patients With Heart Failure With Reduced Ejection Fraction: A Meta-analysis
Author: Jiang, Yinhao; Yang, Ziying; Shao, Lianbo; Shen, Han; Teng, Xiaomei; Chen, Yihuan; Ding, Yinglong; Fan, Jiaming; Yu, You; Shen, Zhenya

Journal: CELL TRANSPLANTATION. 2023; Vol. 32, Issue , pp. -. DOI: 10.1177/09636897231152381